Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Analysis Tool Aids in Identifying Genes that Hijack Enhancers

You know that structural changes in genes are common in cancer, but how can you know which alterations actually drive disease? A new NCI-funded tool called “HAPI” (short for “Highly Active Promoter Interactions”) could help you gain insight into one possible outcome of these genetic changes.

In particular, using HAPI, you can spot structural changes linked to “hijacked” enhancers—DNA sequences that move from one location to another to boost overexpression of cancer-causing genes.

[callout]Read the full report, “3D genomic analysis reveals novel enhancer-hijacking caused by complex structural alterations that drive oncogene overexpression,” in Nature Communications. The HAPI analysis tool is publicly available.[/callout]

Corresponding author, Dr. Katherine Varley, of the University of Utah, said “HAPI not only helps you identify genes that many enhancers influence but also lets you see the location and contribution of those enhancers. This allows you to find HAPI genes that are interacting with enhancers hijacked from another genomic region, likely as a result of structural alterations.”

The authors note that you can use several tools to identify enhancer hijacking, but HAPI is unique because it allows you to prioritize the gene targets and underlying functional enhancers.

Co-corresponding author, Dr. Xiaoyang Zhang, also from the University of Utah, said, “Prioritizing is essential because most of the structural variants are passenger events. They’re passed along but ultimately don’t impact function. With our approach, you can prioritize the ones that are more likely to affect expression of cancer-causing genes.”

This tool could help uncover new therapeutic strategies. As noted by Dr. Zhang, “If we can better understand enhancer hijacking events, we can find new ways to silence oncogenes. By linking hijacked enhancers to structural changes in tumor genomes, we also could identify cancer-specific targets for therapeutics (such as ZNF, TALEN and CRISPR).”

< Older Post

Dr. Jill Barnholtz-Sloan Talks Informatics, Data Science, and Epidemiology in NCI Podcast

Newer Post >

NCI-Funded Tool Helps Characterize Noncoding Elements that Impact Cancer Genes

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Analysis Tool Aids in Identifying Genes that Hijack Enhancers was originally published by the National Cancer Institute.”

Archive

Email